Head to head for first-timers
CoreAge Rx vs NativeMed
CoreAge Rx and NativeMed both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #31 for first-timers · Grade C
Mama-Match
Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Visit CoreAge RxNativeMed
Rank #135 for first-timers · Grade C
Mama-Match
Best for: Someone who wants both prices visible without a quiz and is willing to weigh an FDA letter.
Visit NativeMedThe verdict for a first step
CoreAge Rx edges out NativeMed on the Mama-Match Score, 73 to 58 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
NativeMed is still a genuine option — compounded semaglutide at $149 and tirzepatide at $183, both advertised as sale prices against $299 and $399, with no membership fee and pharmacies described only as USA-based. ⚠ NativeMed carries an FDA warning letter of its own — issued to NativeMed LLC dba NativeMed on 8 June 2026, MARCS-CMS 728287, for false and misleading claims and misbranding in telehealth. We list it and disclose the letter rather than dropping it, because a letter tells you something a reader should weigh and only a shutdown ends a listing. The storefront also sells NAD+ injections and generic sildenafil, tadalafil and trazodone alongside the GLP-1s, so it is a general telehealth catalog rather than a weight-loss practice. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | NativeMed |
|---|---|---|
| Mama-Match Score | 73/100 · C | 58/100 · C |
| Overall rank | #31 | #135 |
| Semaglutide | $99/mo | $149/mo (sale, regular $299) |
| Tirzepatide | $149/mo | $183/mo (sale, regular $399) |
| Coverage | Therapy-specific state restrictions; confirm eligibility | Not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #31 · Grade C
What we like
- Published prices for both molecules, with the same advertised amount at each dose
- The offer includes medication, consultation and shipping, without an advertised membership fee
- The legal footer identifies the platform and the entities responsible for clinical care
The caveats
- The main site and a separate offer page show different prices
- The FAQ and policy differ on automatic rebilling and denial refunds
- State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff
Mama-Match
NativeMed
Rank #135 · Grade C
What we like
- Publishes both molecule prices openly on the homepage, with no quiz in the way
- States plainly that there are no membership fees on top of the medication
- Tirzepatide at $183 is below the median for this roster
The caveats
- ⚠ Carries an FDA warning letter of its own: issued 8 June 2026 to NativeMed LLC dba NativeMed, MARCS-CMS 728287, for false and misleading claims and misbranding in telehealth
- Both prices are advertised as sale prices against a $299 and $399 regular price, with no published end date for the sale
- Pharmacies are described only as USA-based and are never named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and NativeMed with the other providers we review for women.
Or browse the full comparison hub.